Synthesis and Binding Studies of Diethynyl-Pyridine Amides
FULL PAPER
A
E
E
vacuo and the residue was dissolved in water and acidified with formic
acid. The precipitate formed was collected by filtration and washed with
water and diethyl ether to give the crude acid 14 (90.0 mg, 99%) as a
light yellow solid, which was used without further purification. 1H NMR
(500 MHz, [D6]DMSO): d=7.89 (s, 2H), 7.69 (d, J=8.5 Hz, 2H), 6.78 (d,
J=8.5 Hz), 6.53 (s, 2H), 4.91 (s, 4H), 3.33 ppm (s, 4H), the OH group
could not be determined.
dACHTUNGTRENNUNG
or DEPT as well as COSY, NOESY spectra. Mass spectra were recorded
on a Micromass Q-Tof (ESI) spectrometer.
Thin layer chromatography (TLC) was performed on Merck Kieselgel 60
F254 glass plates and visualised under UV light. Flash column chroma-
tography (FC) was performed by using Merck Kieselgel 60 silica gel and
distilled solvents. HPLC was performed by using a Varian Pursuit C18,
5m column (250ꢁ21.2 mm) and a gradient elution with 0.1% TFA/MeCN
Preparation of ligand 4: A mixture of triacid 14 (0.25 mmol), EDC
(1.06 mmol, 4.24 equiv), HOBt (1.06 mmol, 4.24 equiv), NMM
(2.10 mmol, 8.40 equiv), amine 15 (0.78 mmol, 3.12 equiv) in DMF
(5 mL) was stirred at RT overnight. The solvent was removed in vacuo
and the residue was purified by HPLC (gradient: H2O/MeCN (1% TFA)
20:80!MeCN (1% TFA) over 35 min, 12 mLminꢀ1) to give the desired
compounds 4.
Ligand 4a: Yield: 84%; reddish brown oil; 1H NMR (500 MHz, D2O):
d=7.54 (d, J=2.1 Hz, 2H), 7.49 (s, 2H), 7.35 (dd, J=8.6, 2.1 Hz, 2H),
6.58 (d, J=8.6 Hz, 1H), 3.21 (t, J=6.9 Hz, 4H), 3.16 (t, J=6.9 Hz, 2H),
3.05–3.03 (m, 6H), 2.77 (s, 18H), 1.89–1.83 ppm (m, 6H); 13C NMR
(125 MHz, D2O): d=168.9 (s), 165.6 (s), 151.9 (s), 142.5 (s), 141.9 (s),
132.4 (d), 130.1 (d), 123.2 (d), 121.7 (s), 114.5 (d), 104.9 (s), 92.3 (s), 88.1
(s), 55.3 (t), 55.2 (t), 42.68 (q), 42.66 (q), 36.8 (t), 36.4 (t), 24.3 (t),
23.8 ppm (t); HRMS (ESI): m/z calcd for C39H51N9O3: 694.8905 [M+H]+;
found: 694.8916.
Ligand 4b: Yield: 81%; reddish brown oil; 1H NMR (500 MHz,
CD3OD): d=7.75 (s, 2H), 7.51 (d, J=2.1 Hz, 2H), 7.49 (dd, J=8.7,
2.1 Hz, 2H), 6.62 (d, J=8.7 Hz, 2H), 3.33 (t, J=6.8 Hz, 2H), 3.28 (t, J=
6.7 Hz, 4H), 3.20-2.96 (m, 24H), 2.80 (t, J=7.2 Hz, 4H), 2.75–2.72 (m,
2H), 2.69–2.68 (m, 9H), 1.81–1.76 ppm (m, 6H); 13C NMR (125 MHz,
CDCl3): d=169.8 (s), 166.7 (s), 155.1 (s), 145.2 (s), 144.8 (s), 133.8 (d),
131.4 (d), 124.6 (d), 122.4 (s), 114.8 (d), 104.9 (s), 92.2 (s), 89.3 (s), 55.7
(t), 55.6 (t), 53.5 (t), 53.1 (t), 50.9 (t), 50.8 (t), 43.7 (q), 43.6 (q), 38.6 (t),
37.9 (t), 26.5 (t), 26.4 ppm (t); HRMS (ESI): m/z calcd for C48H66N12O3:
859.5459 [M+H]+; found: 859.5450.
and 0.1% TFA/H2O (TFA=trifluoroacetic acid) at
12.0 mLminꢀ1
.
General procedure for synthesis of ligands 3: A mixture of dicarboxylic
acid 8[9b] (397.0 mg, 1.0 mmol), EDC·HCl (814.1 mg, 4.24 mmol), HOBt
(572.8 mg, 4.24 mmol), NMM (849.7 mg, 8.40 mmol) and propargylamine
(275.0 mg, 5.0 mmol, 5 equiv) in DMF (10 mL) was stirred at RT for
10 h. The solvent was removed in vacuo and the residue was dissolved in
water. The precipitate formed was filtered off, washed with water and di-
ethyl ether to give crude product 9 (403.0 mg, 86%) as a dark brown
solid, which was used for click reactions without further purification.
A mixture of crude amide 9 (1 equiv), the aryl azide 10 (5 equiv), sodium
ascorbate (0.2 equiv) and CuSO4·5H2O (10 mol%) in H2O/tBuOH (1:1)
was stirred at RT for 12 h. Removal of the solvent in vacuo and purifica-
tion by HPLC (Solvents: A=Acetonitrile (0.1% TFA), B=H2O (0.1%
TFA) afforded the corresponding products 3a–c.
Ligand 3a: Yield: 87%; red oil; 1H NMR (500 MHz, D2O): d=7.63 (s,
2H), 7.52 (s, 1H), 7.18 (s, 2H), 7.04 (s, 2H), 7.00 (s, 2H), 6.10 (s, 2H),
4.46 (t, J=5.6 Hz, 4H), 3.98 (sbr, 4H), 3.30 ppm (t, J=5.7 Hz, 4H);
13C NMR (125 MHz, D2O): d=167.7 (s), 152.5 (s), 142.4 (d), 136.7 (s),
132.6 (d), 130.6 (d), 126.7 (d), 124.1 (d), 117.3 (s), 115.0 (s), 114.1 (d),
102.5 (s), 94.6 (s), 88.0 (s), 47.1 (t), 38.7 (t), 34.4 ppm (t); HRMS (ESI):
m/z calcd for C33H33N13O2: 644.2958 [M+H]+; found: 644.2944.
Ligand 3b: Yield: 83%; red oil; 1H NMR (500 MHz, D2O): d=7.82 (s,
2H), 7.68 (t, J=8.4 Hz, 1H), 7.39 (s, 2H), 7.24 (d, J=7.4 Hz, 2H), 7.19
(d, J=8.5 Hz, 2H), 6.32 (d, J=8.3 Hz, 2H), 4.71–4.67 (m, 4H, merged
with D2O), 4.21 (s, 4H), 3.67 (t, J=5.9 Hz, 4H), 3.56 (m, 4H), 3.01–2.95
(m, 4H), 2.04–1.96 (m, 4H), 1.88–1.80 ppm (m, 4H); 13C NMR
(125 MHz, D2O): d=167.9 (s), 152.5 (s), 145.4 (s), 137.3 (s), 132.7 (d),
130.4 (d), 126.9 (d), 124.1 (d), 120.9 (s), 114.3 (d), 103.0 (s), 94.1 (s), 88.5
(s), 54.6 (s), 53.5 (s), 46.1 (t), 34.6 (t), 22.5 ppm (t), one aromatic CH
could not be unambiguously determined; HRMS (ESI): m/z calcd for
C41H45N13O2: 752.3897 [M+H]+; found: 752.3926.
Ligand 3c: Yield: 84%; red oil; 1H NMR (500 MHz, D2O): d=7.60 (s,
2H), 7.48 (t, J=7.7 Hz, 1H), 7.19 (s, 2H), 7.03 (d, J=7.4 Hz, 2H), 6.99
(d, J=8.5 Hz, 2H), 6.10 (d, J=8.5 Hz, 2H), 4.22 (t, J=6.7 Hz, 4H), 4.01
(s, 4H), 2.91–2.89 (m, 4H), 2.61 (s, 12H), 2.10–2.08 ppm (m, 4H);
13C NMR (125 MHz, D2O): d=167.6 (s), 152.4 (s), 144.7 (s), 141.7 (d),
137.4 (s), 132.5 (d), 130.4 (d), 126.5 (d), 123.7 (d), 120.4 (d), 113.9 (d),
102.9 (s), 93.5 (s), 88.6 (s), 54.3 (t), 46.9 (t), 42.5 (q), 24.5 ppm (t), one ar-
omatic carbon could not be unambiguously determined; HRMS (ESI):
m/z calcd for C39H45N13O2: 728.3897 [M+H]+; found: 728.3920.
FRET melting experiments: All DNA sequences tested were initially dis-
solved as a 100 mm stock solution in MilliQ (MQ) water. Further dilutions
were carried out in 60 mm potassium cacodylate buffer, pH 7.4. Five dual
fluorescently labelled DNA oligonucleotides were used in these experi-
ments: k-ras was a dual-labelled 32-mer oligonucleotide comprising a
quadruplex forming region in the promoter region of the human k-ras
gene, 5’-FAM-AGG GCGGTG TGG GAA GAG GGA AGA GGG
GGA GG-TAMRA; c-myc was a dual-labelled 22-mer oligonucleotide
comprising one of the quadruplex forming regions in the promoter
region of the human c-myc oncogene, 5’-FAM-TGA GGG TGG GTA
GGG TGG GTA A-TAMRA-3’; c-kit1 was a dual-labelled 21-mer oligo-
nucleotide comprising one of the quadruplex forming regions in the pro-
moter region of the human c-kit oncogene, 5’-FAM-GGG AGG GCG
CTG GGA GGA GGG-TAMRA-3’; c-kit2 was a dual-labelled 20-mer
oligonucleotide comprising one of the quadruplex forming regions in the
promoter region of the human c-kit oncogene, 5’-FAM-GGG CGG GCG
CGA GGG AGG GG-TAMRA-3’; ds-DNA was a dual-labelled 20-mer
oligonucleotide comprising a self-complementary sequence with a central
polyethylene glycol linker able to fold into a hairpin, 5’-FAM-TAT AGC
TAT A HEG TAT AGC TAT A-TAMRA-3’. The donor fluorophore was
6-carboxyfluorescein (FAM), and the acceptor fluorophore was 6-carbox-
ytetramethylrhodamine, (TAMRA). Dual-labelled DNA was annealed at
a concentration of 400 nm by heating at 948C for 5 min followed by cool-
ing to room temperature. One mm stock solution of ligands 3 and 4 were
made up in MQ water. The 96-well plates (MJ Research, Waltham, MA)
were prepared by aliquoting 50 mL of the annealed DNA into each well,
followed by 50 mL of the compound solutions by using a Beckman Coult-
er liquid handling robot. Measurements were made in triplicate with an
excitation wavelength of 483 nm and a detection wavelength of 533 nm
by using a LightCycler 480 System RT-PCR machine (Roche). Final anal-
ysis of the data was carried out by using Origin Pro 7.5 data analysis and
graphing software (OriginLab).
Triester derivative 13: A mixture of iodoaniline derivative 5 (544.0 mg,
2 mmol), diethynyl compound 12 (185.1 mg, 1 mmol), [PdCl2ACTHNUTRGEN(UNG PPh3)2]
(70.2 mg, 10 mol%), and CuI (38 mg, 20 mol%) was evacuated and filled
with argon. To the mixture DMF (10 mL) and triethylamine (2 mL) were
added. After stirring at RT under an argon atmosphere for 9 h, the mix-
ture was dried in vacuo. The residue was purified by chromatography on
silica gel (EtOAc/hexane (1:1)!EtOAc) to afford 13 (353.0 mg,73%) as
a light yellow solid. 1H NMR (500 MHz, CDCl3): d=8.14 (d, J=2.0 Hz,
2H), 7.98 (s, 2H), 7.84 (d, J=2.0 Hz, 2H), 6.70 (d, J=8.6 Hz, 2H), 4.90
(s, 4H), 4.00 (s, 3H), 3.87 ppm (s, 6H); 13C NMR (125 MHz, CDCl3): d=
166.3 (s), 164.4 (s), 152.3 (s), 144.4 (s), 138.5 (s), 135.2 (d), 132.5 (d),
125.2 (d), 119.4 (s), 113.5 (d), 105.1 (s), 93.3 (s), 86.9 (s), 53.1 (q),
51.8 ppm (q); HRMS (ESI): m/z calcd for C27H21N3O6: 484.4721 [M+H]+;
found: 484.4742.
Triacid 14: To a solution of the methyl ester derivative 13 (100.0 mg) in
methanol and THF (1:1, 10 mL) NaOH (5 mL, 2n solution in water) was
added at 08C. After stirring for 12 h at RT, the solvents were removed in
Surface plasmon resonance: Surface plasmon resonance measurements
were performed on
a four-channel BIAcore 3000 optical biosensor
system (Biacore Inc.) by using a streptavidin-coated sensor chip (Biacore
Chem. Eur. J. 2011, 17, 4571 – 4581
ꢀ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4579